NDC 66104-8851-0 - Neo-Terramycin 100/100
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66104-8851
- Requested NDC
- 66104-8851-0
- Package NDCs from labels
- 66104-8851-0
- Manufacturer
- Phibro Animal Health
- Effective date
- 2026-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neo-Terramycin 100/100 - Phibro Animal Health | Phibro Animal Health | 2026-01-21 | VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66104-8851-0 | Neo-Terramycin 100/100 | 22.7 kg in 1 BAG | POWDER | 22.7 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66104-8851 | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 9 | 1 package rows | 20230803_3e2a3dc9-6ae2-4e0c-9e2a-e1cf042c6587.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 | |
| OXYTETRACYCLINE HYDROCHLORIDE | ACTIVE INGREDIENT | 4U7K4N52ZM | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 | |
| OXYTETRACYCLINE | ACTIVE MOIETY | X20I9EN955 | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 | |
| RICE BRAN | INACTIVE INGREDIENT | R60QEP13IC | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 | |
| SODIUM ALUMINIUM SILICATE | INACTIVE INGREDIENT | 058TS43PSM | NEO-TERRAMYCIN 100/100 (NEOMYCIN-OXYTETRACYCLINE) POWDER [PHIBRO ANIMAL HEALTH] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | NuCare Pharmaceutical, Inc. | 5b14499e-e45c-7c05-e063-6294a90a1cc2 | 2026-09-09 | Warnings | 057Y626693 |
| American Safety and First Aid Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | eb0df2da-1688-c477-e053-2995a90a74a2 | 2026-09-07 | Warnings | 057Y626693 |
| American Safety and First Aid Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | eb0d108f-42bf-3364-e053-2a95a90a4542 | 2026-09-07 | Warnings | 057Y626693 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e4d0a4-b90c-99b0-e053-2995a90ab423 | 2026-09-04 | Warnings | 057Y626693 |
| Lil Drug Store Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | ORAZEN INC | e6e5263b-328f-4775-9fac-34302f050ce0 | 2026-09-04 | Warnings | 057Y626693 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e42c5c-e080-4efb-e053-2a95a90af52e | 2026-09-04 | Warnings | 057Y626693 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e4854a-ee01-df72-e053-2995a90aa8ea | 2026-09-04 | Warnings | 057Y626693 |
| Circle K Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | ORAZEN INC | 84c3f7e4-b28b-40bb-8d9d-7c8d679e3a3a | 2026-09-04 | Warnings | 057Y626693 |
| First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL | Walgreen Company | b982091a-5aa0-4bbc-bb1d-08016f6d0a70 | 2026-09-03 | Warnings | 057Y626693 |
| SurviveX Triple Antibiotic | TRIPLE ANTIBIOTIC | Nantong Health & Beyond Hygienic Products Inc. | 5a7cb52d-a60c-b947-e063-6394a90afb0d | 2026-09-02 | Warnings | 057Y626693 |
| Oil | MINERAL OIL | Atlantic Biologicals Corp. | 5a82197b-281d-76c0-e063-6294a90a5746 | 2026-09-02 | Warnings, Adverse reactions | T5L8T28FGP |
| triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Walgreen Company | 4f3cfe39-2df8-48b4-954d-5997217c92ba | 2026-08-31 | Warnings | 057Y626693 |
| Mineral Oil | MINERAL OIL | Your Military Exchanges | 6025dce6-02e8-418c-a248-0b5c33ff6067 | 2026-08-28 | Warnings, Adverse reactions | T5L8T28FGP |
| First Aid Antibiotic | BACITRACIN ZINC | NINGBO TIANBO FIRST AID PRODUCT CO., LTD. | 217aa2b8-94f5-468a-99b4-52824a77b573 | 2026-08-28 | Warnings | 057Y626693 |
| OP Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Yiwu Ori-Power Medtech Co., Ltd. | 03f3cce9-7e9f-90a6-e063-6294a90a660b | 2026-08-28 | Warnings | 057Y626693 |
| Be Smart Get Prepared Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Total Resources International, Inc | 57ed1a03-7e1b-4eb4-8001-dfd118805edc | 2026-08-24 | Warnings | 057Y626693 |
| Claravie | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B | Gentell LLC | 597cb2f0-ff05-a1ab-e063-6294a90acda9 | 2026-08-20 | Warnings | 057Y626693 |
| Mineral Oil/White Petrolatum | MINERAL OIL/WHITE PETROLATUM | YYBA CORP | 5967ef02-6770-bfd7-e063-6294a90a7904 | 2026-08-19 | Warnings | T5L8T28FGP |
| Medpride First Aid | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Shield Line LLC | 5ba3e703-7873-4724-a0bf-bb22d8a25748 | 2026-08-18 | Warnings | 057Y626693 |
| First Aid Antibiotic and Burn Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HYDROCHLORIDE | Amazon.com Services LLC | 3459a453-0a94-4122-adad-bb120daecd9e | 2026-08-18 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.